dbAMP 2.0: updated resource for antimicrobial peptides with an enhanced scanning method for genomic and proteomic data

Author:

Jhong Jhih-Hua1ORCID,Yao Lantian12,Pang Yuxuan12ORCID,Li Zhongyan13,Chung Chia-Ru4,Wang Rulan12,Li Shangfu1,Li Wenshuo12,Luo Mengqi1ORCID,Ma Renfei1,Huang Yuqi3,Zhu Xiaoning3,Zhang Jiahong3,Feng Hexiang3,Cheng Qifan3,Wang Chunxuan1,Xi Kun1,Wu Li-Ching5,Chang Tzu-Hao6,Horng Jorng-Tzong4,Zhu Lizhe13,Chiang Ying-Chih3,Wang Zhuo1ORCID,Lee Tzong-Yi13ORCID

Affiliation:

1. Warshel Institute for Computational Biology, The Chinese University of Hong Kong, Shenzhen 518172, China

2. School of Science and Engineering, The Chinese University of Hong Kong, Shenzhen 518172, China

3. School of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen 518172, China

4. Department of Computer Science and Information Engineering, National Central University, Taoyuan 32001, Taiwan

5. Department of Biomedical Sciences and Engineering, National Central University, Taoyuan 32001, Taiwan

6. Graduate Institute of Biomedical Informatics, Taipei Medical University, Taipei 10675, Taiwan

Abstract

Abstract The last 18 months, or more, have seen a profound shift in our global experience, with many of us navigating a once-in-100-year pandemic. To date, COVID-19 remains a life-threatening pandemic with little to no targeted therapeutic recourse. The discovery of novel antiviral agents, such as vaccines and drugs, can provide therapeutic solutions to save human beings from severe infections; however, there is no specifically effective antiviral treatment confirmed for now. Thus, great attention has been paid to the use of natural or artificial antimicrobial peptides (AMPs) as these compounds are widely regarded as promising solutions for the treatment of harmful microorganisms. Given the biological significance of AMPs, it was obvious that there was a significant need for a single platform for identifying and engaging with AMP data. This led to the creation of the dbAMP platform that provides comprehensive information about AMPs and facilitates their investigation and analysis. To date, the dbAMP has accumulated 26 447 AMPs and 2262 antimicrobial proteins from 3044 organisms using both database integration and manual curation of >4579 articles. In addition, dbAMP facilitates the evaluation of AMP structures using I-TASSER for automated protein structure prediction and structure-based functional annotation, providing predictive structure information for clinical drug development. Next-generation sequencing (NGS) and third-generation sequencing have been applied to generate large-scale sequencing reads from various environments, enabling greatly improved analysis of genome structure. In this update, we launch an efficient online tool that can effectively identify AMPs from genome/metagenome and proteome data of all species in a short period. In conclusion, these improvements promote the dbAMP as one of the most abundant and comprehensively annotated resources for AMPs. The updated dbAMP is now freely accessible at http://awi.cuhk.edu.cn/dbAMP.

Funder

National Natural Science Foundation of China

Guangdong Province Basic and Applied Basic Research Fund

Ganghong Young Scholar Development Fund

Science, Technology and Innovation Commission of Shenzhen Municipality

Chinese University of Hong Kong

Publisher

Oxford University Press (OUP)

Subject

Genetics

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3